On September 28, UiPath fell 6.62% in regular trading, trading at $11.675/share, with turnover of $42.22 million. The decline was primarily triggered by DA Davidson downgrading UiPath from Neutral to Underperform and slashing its price target from $16 to $10, representing the most bearish sell-side call on the stock in recent months.

The downgrade comes amid a wave of analyst target price reductions. UBS recently trimmed its target to $14 from $15, Truist cut its target to $14 from $17, and RBC Capital Markets lowered its target to $15 — all maintaining Hold ratings. RBC noted that UiPath's transition toward its Business Orchestration and Automation Technologies platform remains a show-me story, with limited evidence of growth re-acceleration despite AI-driven deal momentum.

Although UiPath reported Q2 revenue of $410.3 million, beating the $397.8 million consensus, and raised full-year guidance to $1.789-$1.794 billion, flat EPS of $0.15, a CFO transition, and decelerating ARR growth have continued to weigh on investor confidence. The consensus average target now stands at approximately $15.78 with an overall Hold rating.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)